Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treatment for excessive hair growth depends on the cause, with options including hair removal methods and medications like anti-androgens or insulin-sensitizing drugs.

Rare ovarian tumors can cause increased male hormones in postmenopausal women; surgery is an effective treatment.

The document concludes that antiandrogenic drugs like cyproterone acetate and spironolactone are effective but not permanent treatments for skin-related androgenization in women.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

Biochemical markers help diagnose ovarian tumors in postmenopausal women.

Benign ovarian tumors can cause excess male hormones and related conditions in postmenopausal women.

Female hyperandrogenism is a condition caused by too much male hormones, leading to skin issues and ovulation problems, often due to Polycystic Ovary Syndrome, and is treated based on individual symptoms.

A woman's hair loss was linked to a rare hormone-secreting ovarian tumor, treated with surgery and hair loss medication.

Hirsutism and androgenetic alopecia in women are often due to increased androgen effects, and antiandrogen treatment is recommended to prevent further issues.

A woman had high testosterone due to an ovarian issue, which was fixed with surgery.

New treatments for excessive hair growth in women, including advanced drugs and nanotechnology, show promise for better results.

The case showed the need for quick investigation of virilization in women and how emotional health is linked to physical health.

Skin symptoms like fragile skin and easy bruising can indicate Cushing's syndrome, which requires early diagnosis and treatment to prevent serious health issues.

Hirsutism, excessive male-pattern hair in women, can be caused by high androgens or skin sensitivity, diagnosed by testosterone levels, and treated with hair removal and hormone therapy.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Doctors should check for serious tumor causes of high androgen levels in postmenopausal women and more research is needed on this condition.

Anabolic androgenic steroids can increase cancer risk and disrupt hormones.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

Leydig cells can cause testosterone-secreting adrenal tumors in women.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Hirsutism involves excessive hair growth due to hormonal issues and can be treated with medication or surgery.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

Hirsutism in women is mostly caused by polycystic ovary syndrome and idiopathic hyperandrogenism.